Smruthi Organic

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE172E01011
NSEID:
BSEID: 540686
View on BSE

INR

116.10

-2.2 (-1.86%)

BSENSE

May 14

BSE+NSE Vol: 1.1 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Godavari Drugs

Smruthi Organic

Tyche Industries

Brooks Lab.

Lactose (India)

Bal Pharma

Alpa Laboratorie

Sotac Pharma.

Krebs Biochem

Achyut Healthcar

Accretion Pha.

Why is Smruthi Organics Ltd ?

Poor long term growth as Net Sales has grown by an annual rate of -2.78% and Operating profit at -19.96% over the last 5 years

Flat results in Mar 26

NET SALES(Latest six months) At Rs 51.38 cr has Grown at -25.90%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -1.61% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Smruthi Organic for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Smruthi Organic

-1.61%

-0.03

50.48%

Sensex

-7.29%

-0.56

13.06%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.78%

EBIT Growth (5y)

-19.96%

EBIT to Interest (avg)

6.32

Debt to EBITDA (avg)

0.86

Net Debt to Equity (avg)

0.11

Sales to Capital Employed (avg)

1.64

Tax Ratio

26.34%

Dividend Payout Ratio

48.19%

Pledged Shares

Institutional Holding

ROCE (avg)

13.43%

ROE (avg)

9.85%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.81

EV to EBIT

20.76

EV to EBITDA

10.66

EV to Capital Employed

1.74

EV to Sales

1.36

PEG Ratio

4.96

Dividend Yield

1.29%

ROCE (Latest)

8.40%

ROE (Latest)

5.20%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

PAT(9M)

Higher at Rs 4.92 Cr

-3What is not working for the Company

NET SALES(Latest six months)

At Rs 51.38 cr has Grown at -25.90%

Loading Valuation Snapshot...

Here's what is working for Smruthi Organic

Profit After Tax (PAT) - Nine Monthly

Higher at Rs 4.92 Cr

than preceding 12 month period ended Mar 2026 of Rs 3.39 cr

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)

Here's what is not working for Smruthi Organic

Net Sales - Latest six months

At Rs 51.38 cr has Grown at -25.90%

Year on Year (YoY)

MOJO Watch

Near term sales trend is negative

Net Sales (Rs Cr)